Touch Imprint Cytology of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Carcinoma

Cancer

Volumn 99, Issue 6, 2003, Pages 346-351

  Jain, Paresh ^a   Kumar, Rajive ^a,b   Anand, Mona ^a   Asthana, Sonal ^a   Deo, Suryanarayana V S ^a   Gupta, Ritu ^a   Bhutani, Manisha ^a   Karak, Asis K ^b   Shukla, Nootan K ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Axillary lymph node metastasis; Breast carcinoma; Imprint cytology; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; FEMALE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SENTINEL LYMPH NODE; TUMOR CELL; TUMOR NECROSIS;

ADULT; AGED; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NECROSIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0347512117     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11825     Document Type: Article

References (22)

1. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483-2493.
2. Kuerer HM, Sahin AA, Hunt KK, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230:72-78.
3. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18:3480-3486.
4. Haid A, Tausch C, Lang A, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer. 2001;92:1080-1084.
5. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg. 2001;182:312-315.
6. Julian TB, Patel N, Dusi D, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2000;182:407-410.
7. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002;9:235-242.
8. Motomura K, Inaji H, Komoike Y, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg. 2000;87:597-601.
9. Quill DS, Leahy AL, Lawler RG, Finney RD. Lymph node imprint cytology for the rapid assessment of axillary node metastases in breast cancer. Br J Surg. 1984;7:454-455.
10. Anastasiadis PG, Koutlaki NG, Liberis VA, Skaphida PG, Tsikouras PN, Galazios GC. Cytologic diagnosis of axillary lymph node metastasis in breast cancer. Acta Cytol. 2000;44:18-22.
11. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000;24:1266-1272.
12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-398.
13. Kinne DW. Staging and follow-up of breast cancer patients. Cancer. 1991;67:1196-1198.
14. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol. 1998;5:689-694.
15. Ratanawichitrasin A, Biscotti CV, Levy L, Crowe JP. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg. 1999;86:1346-1348.
16. Llatjos M, Castella E, Fraile M, et al. Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma: accuracy of rapid imprint cytology compared with definitive histologic workup. Cancer (Cancer Cytopathol). 2002;96:150-156.
17. Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer (Cancer Cytopathol). 2002;96:225-231.
18. Creager AJ, Geisinger KR, Shiver SA, et al. Intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma by imprint cytology. Mod Pathol. 2002;15:1140-1147.
19. Allred DC, Elledge RM. Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes. Cancer. 1999;86:905-907.
20. Dowlatshahi K. The significance of micrometastasis. In: Cody HS, editor. Sentinel lymph node biopsy. London: Martin Dunitz Ltd., 2002:311-319.
21. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979;40:2163-2177.
22. Geller NL, Bosl GJ, Chan EY, Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors. Cancer. 1989;63:440-445.